Harnessing innate lung anti-cancer effector functions with a novel bacterial-derived immunotherapy

Reference

• Kucerova P, Cervinkova M. Spontaneous regression of tumour and the role of microbial infection – possibilities for cancer treatment. Anticancer Drugs. 2016;27:269–77. doi:10.1097/CAD.0000000000000337. PMID:26813865
   PubMed Web of Science ®Google Scholar
• Coley WB II. Contribution to the knowledge of sarcoma. Ann Surg. 1891;14:199–220. doi:10.1097/00000658-189112000-00015. PMID:17859590
   PubMedGoogle Scholar
• Coley WB. The treatment of inoperable sarcoma by bacterial toxins (the Mixed Toxins of the Streptococcus erysipelas and the Bacillus prodigiosus). Proc R Soc Med. 1910;3:1–48. PMID:19974799
   PubMedGoogle Scholar
• Redelman-Sidi G, Glickman MS, Bochner BH. The mechanism of action of BCG therapy for bladder cancer–a current perspective. Nat Rev Urol. 2014;11:153–62. doi:10.1038/nrurol.2014.15. PMID:24492433
   PubMed Web of Science ®Google Scholar
• Felgner S, Kocijancic D, Frahm M, Weiss S. Bacteria in cancer therapy: Renaissance of an old concept. Int J Microbiol. 2016;2016:8451728. doi:10.1155/2016/8451728. PMID:27051423
   PubMedGoogle Scholar
• Lizotte PH, Baird JR, Stevens CA, Lauer P, Green WR, Brockstedt DG, Fiering SN. Attenuated Listeria monocytogenes reprograms M2-polarized tumor-associated macrophages in ovarian cancer leading to iNOS-mediated tumor cell lysis. Oncoimmunology. 2014;3:e28926. doi:10.4161/onci.28926. PMID:25083323
   PubMed Web of Science ®Google Scholar
• Pan ZK, Weiskirch LM, Paterson Y. Regression of established B16F10 melanoma with a recombinant Listeria monocytogenes vaccine. Cancer Res. 1999;59:5264–9. PMID:10537307
   PubMed Web of Science ®Google Scholar
• Baird JR, Byrne KT, Lizotte PH, Toraya-Brown S, Scarlett UK, Alexander MP, Sheen MR, Fox BA, Bzik DJ, Bosenberg M, et al. Immune-mediated regression of established B16F10 melanoma by intratumoral injection of attenuated Toxoplasma gondii protects against rechallenge. J Immunol. 2013;190:469–78. doi:10.4049/jimmunol.1201209. PMID:23225891
   PubMed Web of Science ®Google Scholar
• Sanders KL, Fox BA, Bzik DJ. Attenuated Toxoplasma gondii stimulates immunity to pancreatic cancer by manipulation of myeloid cell populations. Cancer Immunol Res. 2015;3:891–901. doi:10.1158/2326-6066.CIR-14-0235. PMID:25804437
   PubMed Web of Science ®Google Scholar
• Baird JR, Fox BA, Sanders KL, Lizotte PH, Cubillos-Ruiz JR, Scarlett UK, Rutkowski MR, Conejo-Garcia JR, Fiering S, Bzik DJ. Avirulent Toxoplasma gondii generates therapeutic antitumor immunity by reversing immunosuppression in the ovarian cancer microenvironment. Cancer Res. 2013;73:3842–51. doi:10.1158/0008-5472.CAN-12-1974. PMID:23704211
   PubMed Web of Science ®Google Scholar
• Sottnik JL, U'Ren LW, Thamm DH, Withrow SJ, Dow SW. Chronic bacterial osteomyelitis suppression of tumor growth requires innate immune responses. Cancer Immunol Immunother. 2010;59:367–78. doi:10.1007/s00262-009-0755-y. PMID:19701748
   PubMed Web of Science ®Google Scholar
• Lascelles BDX, Dernell WS, Correa MT, Lafferty M, Devitt CM, Kuntz CA, Straw RC, Withrow SJ. Improved survival associated with postoperative wound infection in dogs treated with limb-salvage surgery for osteosarcoma. Ann Surg Oncol. 2005;12:1073–83. doi:10.1245/ASO.2005.01.011. PMID:16252138
   PubMed Web of Science ®Google Scholar
• Jeys LM, Grimer RJ, Carter SR, Tillman RM, Abudu A. Post operative infection and increased survival in osteosarcoma patients: Are they associated? Ann Surg Oncol. 2007;14:2887–95. doi:10.1245/s10434-007-9483-8. PMID:17653803
   PubMed Web of Science ®Google Scholar
• Chen YU, Xu SF, Xu M, Yu XXC. Postoperative infection and survival in osteosarcoma patients: Reconsideration of immunotherapy for osteosarcoma. Mol Clin Oncol. 2015;3:495–500. doi:10.3892/mco.2015.528. PMID:26137256
   PubMedGoogle Scholar
• Bazett M, Biala A, Huff RD, Bosiljcic M, Gunn H, Kalyan S, Hirota JA. A novel microbe-based treatment that attenuates the inflammatory profile in a mouse model of allergic airway disease. Sci. Rep. 2016;6:35338. doi:10.1038/srep35338. PMID:27734946
   PubMed Web of Science ®Google Scholar
• Bazett M, Biala A, Huff RD, Zeglinksi MR, Hansbro PM, Bosiljcic M, Gunn H, Kalyan S, Hirota JA. Attenuating immune pathology using a microbial-based intervention in a mouse model of cigarette smoke-induced lung inflammation. Respir Res. 2017;18:92. doi:10.1186/s12931-017-0577-y. PMID:28506308
   PubMed Web of Science ®Google Scholar
• Fidler IJ, Nicolson GL. Organ selectivity for implantation survival and growth of B16 melanoma variant tumor lines. J. Natl. Cancer Inst. 1976;57:1199–202. doi:10.1093/jnci/57.5.1199. PMID:1003551
   PubMed Web of Science ®Google Scholar
• Butler KL, Clancy-Thompson E, Mullins DW. CXCR3+ monocytes/macrophages are required for establishment of pulmonary metastases. Sci. Rep. 2017;7:45593. doi:10.1038/srep45593. PMID:28358049
   PubMed Web of Science ®Google Scholar
• Clancy-Thompson E, Perekslis TJ, Croteau W, Alexander MP, Chabanet TB, Turk MJ, Huang YH, Mullins DW. Melanoma induces, and adenosine suppresses, CXCR3-Cognate chemokine production and T-cell infiltration of lungs bearing metastatic-like disease. Cancer Immunol Res. 2015;3:956–67. doi:10.1158/2326-6066.CIR-15-0015. PMID:26048575
   PubMed Web of Science ®Google Scholar
• Bedoui S, Heath WR, Mueller SN. CD4+ T-cell help amplifies innate signals for primary CD8+ T-cell immunity. Immunol Rev. 2016;272:52–64. doi:10.1111/imr.12426. PMID:27319342
   PubMed Web of Science ®Google Scholar
• Yuan A, Hsiao YJ, Chen HY, Chen HW, Ho CC, Chen YY, Liu YC, Hong TH, Yu SL, Chen JJ, et al. Opposite effects of M1 and M2 macrophage subtypes on lung cancer progression. Sci Rep. 2015;5:14273. doi:10.1038/srep14273. PMID:26399191
   PubMed Web of Science ®Google Scholar
• Quatromoni JG, Eruslanov E. Tumor-associated macrophages: function, phenotype, and link to prognosis in human lung cancer. Am J Transl Res. 2012;4:376–89. PMID:23145206
   PubMed Web of Science ®Google Scholar
• Zhou Z, Zhang C, Zhang J, Tian Z. Macrophages help NK cells to attack tumor cells by stimulatory NKG2D ligand but protect themselves from NK killing by inhibitory ligand Qa-1. PLoS One. 2012;7:e36928. doi:10.1371/journal.pone.0036928. PMID:22629344
   PubMed Web of Science ®Google Scholar
• Kitaichi N, Kotake S, Morohashi T, Onoé K, Ohno S, Taylor AW. Diminution of experimental autoimmune uveoretinitis (EAU) in mice depleted of NK cells. J Leukoc Biol. 2002;72:1117–21. PMID:12488492
   PubMed Web of Science ®Google Scholar
• Morvan MG, Lanier LL. NK cells and cancer: you can teach innate cells new tricks. Nat Rev Cancer. 2016;16:7–19. doi:10.1038/nrc.2015.5. PMID:26694935
   PubMed Web of Science ®Google Scholar
• Lanier LL. NKG2D receptor and its ligands in host defense. Cancer Immunol Res. 2015;3:575–82. doi:10.1158/2326-6066.CIR-15-0098. PMID:26041808
   PubMed Web of Science ®Google Scholar
• Eissmann P, Evans JH, Mehrabi M, Rose EL, Nedvetzki S, Davis DM. Multiple mechanisms downstream of TLR-4 stimulation allow expression of NKG2D ligands to facilitate macrophage/NK cell crosstalk. J Immunol. 2010;184:6901–9. doi:10.4049/jimmunol.0903985. PMID:20488792
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66:7–30. doi:10.3322/caac.21332. PMID:26742998
   PubMed Web of Science ®Google Scholar
• Luo Y, Chen X, O'Donnell MA. Mycobacterium bovis bacillus Calmette-Guérin (BCG) induces human CC- and CXC-chemokines in vitro and in vivo. Clin Exp Immunol. 2007;147:370–8. doi:10.1111/j.1365-2249.2006.03288.x. PMID:17223980
   PubMed Web of Science ®Google Scholar
• Boettcher S, Manz MG. Regulation of inflammation- and infection-driven hematopoiesis. Trends Immunol. 2017;38:345–57. doi:10.1016/j.it.2017.01.004. PMID:28216309
   PubMed Web of Science ®Google Scholar
• Goutagny N, Estornes Y, Hasan U, Lebecque S, Caux C. Targeting pattern recognition receptors in cancer immunotherapy. Target Oncol. 2012;7:29–54. doi:10.1007/s11523-012-0213-1. PMID:22399234
   PubMed Web of Science ®Google Scholar
• Wu P, Wu D, Zhao L, Huang L, Chen G, Shen G, Huang J, Chai Y. Inverse role of distinct subsets and distribution of macrophage in lung cancer prognosis: a meta-analysis. Oncotarget. 2016;7:40451–60. doi:10.18632/oncotarget.9625. PMID:27248173
   PubMed Web of Science ®Google Scholar
• Ren F, Fan M, Mei J, Wu Y, Liu C, Pu Q, You Z, Liu L. Interferon-γ and celecoxib inhibit lung-tumor growth through modulating M2/M1 macrophage ratio in the tumor microenvironment. Drug Des Devel Ther. 2014;8:1527–38. PMID:25284985
   PubMed Web of Science ®Google Scholar
• Ruffell B, Coussens LM. Macrophages and therapeutic resistance in cancer. Cancer Cell. 2015;27:462–72. doi:10.1016/j.ccell.2015.02.015. PMID:25858805
   PubMed Web of Science ®Google Scholar
• Baldo BA. Side effects of cytokines approved for therapy. Drug Saf. 2014;37:921–43. doi:10.1007/s40264-014-0226-z. PMID:25270293
   PubMed Web of Science ®Google Scholar
• Kloss M, Decker P, Baltz KM, Baessler T, Jung G, Rammensee HG, Steinle A, Krusch M, Salih HR. Interaction of monocytes with NK cells upon Toll-like receptor-induced expression of the NKG2D ligand MICA. J Immunol. 2008;181:6711–9. doi:10.4049/jimmunol.181.10.6711. PMID:18981088
   PubMed Web of Science ®Google Scholar
• Zwirner NW, Domaica CI. Cytokine regulation of natural killer cell effector functions. BioFactors. 2010;36:274–88. doi:10.1002/biof.107. PMID:20623510
   PubMed Web of Science ®Google Scholar
• Skak K, Frederiksen KS, Lundsgaard D. Interleukin-21 activates human natural killer cells and modulates their surface receptor expression. Immunology. 2008;123;575–83. doi:10.1111/j.1365-2567.2007.02730.x. PMID:18005035
   PubMed Web of Science ®Google Scholar
• Lapaque N, Walzer T, Méresse S, Vivier E, Trowsdale J. Interactions between human NK cells and macrophages in response to Salmonella infection. J Immunol. 2009;182:4339–48. doi:10.4049/jimmunol.0803329. PMID:19299734
   PubMed Web of Science ®Google Scholar
• Tieng V, Le Bouguénec C, du Merle L, Bertheau P, Desreumaux P, Janin A, Charron D, Toubert A. Binding of Escherichia coli adhesin AfaE to CD55 triggers cell-surface expression of the MHC class I-related molecule MICA. Proc Natl Acad Sci U. S. A. 2002;99:2977–82. doi:10.1073/pnas.032668099. PMID:11830641
   PubMed Web of Science ®Google Scholar
• Miyazaki J, et al. The liposome-incorporating cell wall skeleton of Mycobacterium bovis bacillus Calmette-Guéin can directly enhance the susceptibility of cancer cells to lymphokine-activated killer cells through up-regulation of natural-killer group 2, member D liga. BJU Int. 2011;108:1520–6. doi:10.1111/j.1464-410X.2010.10056.x. PMID:21314815
   PubMed Web of Science ®Google Scholar
• Malhotra A, Shanker A. NK cells: immune cross-talk and therapeutic implications. Immunotherapy. 2011;3:1143–66. doi:10.2217/imt.11.102. PMID:21995569
   PubMed Web of Science ®Google Scholar
• Mu CY, Huang JA, Chen Y, Chen C, Zhang XG. High expression of PD-L1 in lung cancer may contribute to poor prognosis and tumor cells immune escape through suppressing tumor infiltrating dendritic cells maturation. Med Oncol. 2011;28:682–8. doi:10.1007/s12032-010-9515-2. PMID:20373055
   PubMed Web of Science ®Google Scholar
• D'Incecco A, Andreozzi M, Ludovini V, Rossi E, Capodanno A, Landi L, Tibaldi C, Minuti G, Salvini J, Coppi E, et al. PD-1 and PD-L1 expression in molecularly selected non-small-cell lung cancer patients. Br J Cancer. 2015;112:95–102. doi:10.1038/bjc.2014.555. PMID:25349974
   PubMed Web of Science ®Google Scholar
• Rolfo C, Caglevic C, Santarpia M, Araujo A, Giovannetti E, Gallardo CD, Pauwels P, Mahave M. Immunotherapy in NSCLC: A promising and revolutionary weapon. Adv Exp Med Biol. 2017;995:97–125. doi:10.1007/978-3-319-53156-4_5. PMID:28321814
   PubMed Web of Science ®Google Scholar
• Kadono T. Immune-related adverse events by immune checkpoint inhibitors. Nihon Rinsho Men'eki Gakkai kaishi (Japanese J. Clin. Immunol. 2017;40:83–9. doi:10.2177/jsci.40.83.
   PubMedGoogle Scholar
• Netea MG, et al. Trained immunity: A program of innate immune memory in health and disease. Science. 2016;352;427. doi:10.1126/science.aaf1098.
   Web of Science ®Google Scholar
• Kleinnijenhuis J, Quintin J, Preijers F, Joosten LA, Jacobs C, Xavier RJ, van der Meer JW, van Crevel R, Netea MG. BCG-induced trained immunity in NK cells: Role for non-specific protection to infection. Clin Immunol. 2014;155:213–9. doi:10.1016/j.clim.2014.10.005. PMID:25451159
   PubMed Web of Science ®Google Scholar
• Rouzaire P, Luci C, Blasco E, Bienvenu J, Walzer T, Nicolas JF, Hennino A. Natural killer cells and T cells induce different types of skin reactions during recall responses to haptens. Eur J Immunol. 2012;42:80–8. doi:10.1002/eji.201141820. PMID:21968602
   PubMed Web of Science ®Google Scholar
• Hendricks DW, Balfour HH Jr, Dunmire SK, Schmeling DO, Hogquist KA, Lanier LL. Cutting edge: NKG2 C(hi)CD57+ NK cells respond specifically to acute infection with cytomegalovirus and not Epstein-Barr virus. J Immunol. 2014;192:4492–6. doi:10.4049/jimmunol.1303211. PMID:24740502
   PubMed Web of Science ®Google Scholar
• Venkatasubramanian S, Cheekatla S, Paidipally P, Tripathi D, Welch E, Tvinnereim AR, Nurieva R, Vankayalapati R. IL-21-dependent expansion of memory-like NK cells enhances protective immune responses against Mycobacterium tuberculosis. Mucosal Immunol. 2017;10:1031–42. doi:10.1038/mi.2016.105. PMID:27924822
   PubMed Web of Science ®Google Scholar
• Summers C, Rankin SM, Condliffe AM, Singh N, Peters AM, Chilvers ER. Neutrophil kinetics in health and disease. Trends Immunol. 2010;31:318–24. doi:10.1016/j.it.2010.05.006. PMID:20620114
   PubMed Web of Science ®Google Scholar
• O'Brien MER, Anderson H, Kaukel E, O'Byrne K, Pawlicki M, Von Pawel J, Reck M; SR-ON-12 Study Group. SRL172 (killed Mycobacterium vaccae) in addition to standard chemotherapy improves quality of life without affecting survival, in patients with advanced non-small-cell lung cancer: phase III results. Ann Oncol. 2004;15:906–14. doi:10.1093/annonc/mdh220. PMID:15151947
   PubMed Web of Science ®Google Scholar
• Bugge TH, Kombrinck KW, Xiao Q, Holmbäck K, Daugherty CC, Witte DP, Degen JL. Growth and dissemination of Lewis lung carcinoma in plasminogen-deficient mice. Blood. 1997;90:4522–31. PMID:9373263
   PubMed Web of Science ®Google Scholar
• Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Methods. 2012;9:671–5. doi:10.1038/nmeth.2089. PMID:22930834
   PubMed Web of Science ®Google Scholar
• Yu YRA, O'Koren EG, Hotten DF, Kan MJ, Kopin D, Nelson ER, Que L, Gunn MD. A Protocol for the comprehensive flow cytometric analysis of immune cells in normal and inflamed murine non-lymphoid tissues. PLoS One. 2016;11:e0150606. doi:10.1371/journal.pone.0150606. PMID:26938654
   PubMed Web of Science ®Google Scholar